Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
24
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Kimco Realty
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts
Grocery Anchors And AI Will Shape Retail Future Despite Risks
Key Takeaways Focus on grocery-anchored centers and capital recycling strengthens portfolio resilience, supports long-term earnings growth, and enhances margins. Innovation in leasing and expense recovery processes is increasing efficiency, reducing costs, and improving free cash flow.
View narrative
US$24.23
FV
8.4% undervalued
intrinsic discount
2.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
2 days ago
author updated this narrative
Tenet Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts
Demographic Trends And Technology Efficiency Will Transform Healthcare Delivery
Key Takeaways Expansion in high-acuity and outpatient services, paired with technology investments, is driving stronger margins and sustained earnings growth. Improved payer mix and disciplined capital management are enhancing revenue stability and supporting future financial flexibility.
View narrative
US$197.52
FV
9.1% undervalued
intrinsic discount
3.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
2 days ago
author updated this narrative
Amcor
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Berry Integration And Portfolio Optimization Will Fuel Eco-Friendly Packaging
Key Takeaways Strategic acquisitions, portfolio optimization, and sustainability initiatives strengthen market position, margin expansion, and consistent earnings growth. Broadened footprint in high-growth regions and markets enables Amcor to capture rising demand and evolving industry trends.
View narrative
US$11.04
FV
21.1% undervalued
intrinsic discount
17.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
2 days ago
author updated this narrative
Micron Technology
AN
AnalystConsensusTarget
Consensus Narrative from 34 Analysts
AI And Data Center Demand Will Drive Advanced Memory Expansion
Key Takeaways Surging demand for advanced memory in AI and data centers is driving pricing power, revenue growth, and a shift toward higher-margin products. Strategic investments and a focus on high-value markets are expanding margins and supporting sustainable shareholder returns.
View narrative
US$149.71
FV
21.4% undervalued
intrinsic discount
16.46%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
0
users have commented on this narrative
395
users have followed this narrative
2 days ago
author updated this narrative
Gilead Sciences
AN
AnalystConsensusTarget
Consensus Narrative from 24 Analysts
Global Healthcare Trends Will Expand Access To Advanced Therapies
Key Takeaways New product launches and expanded global access are driving revenue growth and improving Gilead's product mix, reducing reliance on legacy drugs. Strong cash flow and disciplined expense management enable share buybacks and margin expansion, supporting sustainable earnings and capital returns.
View narrative
US$123.75
FV
7.3% undervalued
intrinsic discount
3.71%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
97
users have followed this narrative
2 days ago
author updated this narrative
Regeneron Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 23 Analysts
Broad Pipeline And Global Access Will Build Future Success
Key Takeaways Expanding pipeline, new indications, and emerging market access position the company for sustained revenue growth and increased long-term earnings. Ongoing R&D investment and advanced manufacturing provide cost advantages and margin protection amid shifts toward breakthrough technologies and personalized medicine.
View narrative
US$716.78
FV
17.8% undervalued
intrinsic discount
5.16%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
2
users have commented on this narrative
61
users have followed this narrative
2 days ago
author updated this narrative
Mondelez International
AN
AnalystConsensusTarget
Consensus Narrative from 24 Analysts
Robust Pricing And Brand Collaborations Will Unlock Global Potential
Key Takeaways Mondelez's global pricing strategy and strategic growth agenda aim to increase revenue and market share, especially in Europe and emerging markets. Innovative brand activations and sustainability initiatives are expected to enhance consumer engagement, brand loyalty, and long-term value creation.
View narrative
US$74.44
FV
14.8% undervalued
intrinsic discount
4.83%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
78
users have followed this narrative
2 days ago
author updated this narrative
Bristol-Myers Squibb
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts
Aging Demographics And Genomics Will Drive Healthcare Demand
Key Takeaways An expanding pipeline, strategic partnerships, and strong global launches are driving growth and offsetting competition and patent challenges. Operational streamlining and investment in high-value clinical programs support margin improvement and long-term financial stability.
View narrative
US$53.00
FV
9.6% undervalued
intrinsic discount
-4.72%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
182
users have followed this narrative
2 days ago
author updated this narrative
Automatic Data Processing
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Cloud Based HR Solutions Will Transform Global Workforce Management
Key Takeaways Enhanced AI-driven offerings and integration of acquisitions are improving margins, operational efficiency, and locking in higher per-user revenue through advanced HR solutions. Broadening partnerships and international expansion are diversifying the client base and fueling recurring and long-term revenue growth across global and small business segments.
View narrative
US$320.25
FV
3.8% undervalued
intrinsic discount
5.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
79
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies